Page 3 - Optune Lua News Today

NovoCure Limited (NASDAQ:NVCR – Free Report) – Wedbush upped their Q1 2024 earnings estimates for NovoCure in a research report issued to clients and investors on Thursday, February 22nd. Wedbush analyst D. Nierengarten now expects that the medical equipment provider will post earnings of ($0.36) per share for the quarter, up from their prior estimate […]

NovoCure Limited (NASDAQ:NVCR – Free Report) – Equities research analysts at Wedbush increased their Q1 2024 earnings per share (EPS) estimates for shares of NovoCure in a research note issued to investors on Thursday, February 22nd. Wedbush analyst D. Nierengarten now anticipates that the medical equipment provider will post earnings per share of ($0.36) for […]

NovoCure (NASDAQ:NVCR – Free Report) had its price target hoisted by Evercore ISI from $14.00 to $15.00 in a research report report published on Friday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the medical equipment provider’s stock. A number of other equities research analysts also recently weighed in on the company. […]

NovoCure Limited (NASDAQ:NVCR – Free Report) – Stock analysts at HC Wainwright issued their FY2028 earnings estimates for NovoCure in a note issued to investors on Thursday, February 22nd. HC Wainwright analyst E. Bodnar expects that the medical equipment provider will post earnings of ($1.01) per share for the year. HC Wainwright has a “Buy” […]

NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have assigned a buy recommendation to the […]

NVCR earnings call for the period ending December 31, 2023.

NVCR earnings call for the period ending December 31, 2023.

Aigen Investment Management LP bought a new stake in NovoCure Limited (NASDAQ:NVCR – Free Report) in the 3rd quarter, HoldingsChannel reports. The firm bought 45,433 shares of the medical equipment provider’s stock, valued at approximately $734,000. Several other large investors have also modified their holdings of the business. US Bancorp DE grew its stake in […]

Van ECK Associates Corp increased its holdings in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 6.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,073 shares of the medical equipment provider’s stock after purchasing an additional 959 shares during the period. […]

NovoCure (NASDAQ:NVCR – Get Free Report) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Analyst Ratings This is a breakdown of […]